Buckeyes - "And let's not forget, that Hepa is already negotiated in for 50% of the BoM2 trial ... I believe, right?"

Almost! They are committed for up to 50% and only on costs in China. 

"up to 50% of the trial to be conducted in China with costs to be paid by Shenzhen Hepalink Pharmaceutical “Hepalink”"